Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia

OBJECTIVE: To examine neurodegenerative imaging biomarkers in Alzheimer disease (AD) dementia from middle to old age. METHODS: Persons with AD dementia and elevated brain β-amyloid with Pittsburgh compound B (PiB)-PET imaging underwent [(18)F]-fluorodeoxyglucose (FDG)-PET and structural MRI. We eval...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neurology
Glavni autori: Knopman, David S., Jack, Clifford R., Wiste, Heather J., Weigand, Stephen D., Vemuri, Prashanthi, Lowe, Val J., Kantarci, Kejal, Gunter, Jeffrey L., Senjem, Matthew L., Mielke, Michelle M., Machulda, Mary M., Roberts, Rosebud O., Boeve, Bradley F., Jones, David T., Petersen, Ronald C.
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2016
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4999168/
https://ncbi.nlm.nih.gov/pubmed/27421543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000002979
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items